YDES — YD Bio Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
Annual cashflow statement for YD Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.051 | 0.014 | -1.41 | -8.31 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 0.113 | 0.051 | -0.603 | 3.19 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.004 | -0.123 | 0.073 | -1.69 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Cash from Operating Activities | 0.07 | -0.056 | -1.84 | -6.6 |
| Capital Expenditures | 0 | -0 | -2.91 | -1.44 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -0.067 | 0 | 0.01 | — |
| Change in Net Investments | ||||
| Cash from Investing Activities | -0.067 | -0 | -2.9 | -1.44 |
| Financing Cash Flow Items | — | — | — | -3.05 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -0.072 | 0.114 | 7.73 | 10.9 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.076 | 0.057 | 3.05 | 2.88 |